BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27617475)

  • 1. The impact of immunohistochemistry on the classification of lung tumors.
    Pelosi G; Scarpa A; Forest F; Sonzogni A
    Expert Rev Respir Med; 2016 Oct; 10(10):1105-21. PubMed ID: 27617475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.
    Pelosi G; Fabbri A; Bianchi F; Maisonneuve P; Rossi G; Barbareschi M; Graziano P; Cavazza A; Rekhtman N; Pastorino U; Scanagatta P; Papotti M
    J Thorac Oncol; 2012 Feb; 7(2):281-90. PubMed ID: 22071786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.
    Yatabe Y; Dacic S; Borczuk AC; Warth A; Russell PA; Lantuejoul S; Beasley MB; Thunnissen E; Pelosi G; Rekhtman N; Bubendorf L; Mino-Kenudson M; Yoshida A; Geisinger KR; Noguchi M; Chirieac LR; Bolting J; Chung JH; Chou TY; Chen G; Poleri C; Lopez-Rios F; Papotti M; Sholl LM; Roden AC; Travis WD; Hirsch FR; Kerr KM; Tsao MS; Nicholson AG; Wistuba I; Moreira AL
    J Thorac Oncol; 2019 Mar; 14(3):377-407. PubMed ID: 30572031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
    Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
    J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice.
    Rossi G; Pelosi G; Barbareschi M; Graziano P; Cavazza A; Papotti M
    Int J Surg Pathol; 2013 Aug; 21(4):326-36. PubMed ID: 23740564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple marker composed of p16, CD56, and TTF1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens.
    Švajdler M; Mezencev R; Šašková B; Ondič O; Mukenšnábl P; Michal M
    Hum Pathol; 2019 Mar; 85():58-64. PubMed ID: 30385371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
    Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
    J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
    Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
    Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
    Pelosi G; Fabbri A; Papotti M; Rossi G; Cavazza A; Righi L; Tamborini E; Perrone F; Settanni G; Busico A; Testi MA; Maisonneuve P; De Braud F; Garassino M; Valeri B; Sonzogni A; Pastorino U
    J Thorac Oncol; 2015 Nov; 10(11):1560-9. PubMed ID: 26317919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
    Fang F; Wang YX; Hu ST; Yang L; Di J; Liu DG; Lyu N
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):432-437. PubMed ID: 29886587
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of the immunohistochemical marker p40 in the differential diagnosis of adenocarcinoma and nonkeratinizing squamous cell cancer of the lung].
    Olyushina EM; Byakhova MM; Zavalishina LE; Andreeva YY; Semenova AB; Frank GA
    Arkh Patol; 2020; 82(5):50-56. PubMed ID: 33054032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P40 expression in small cell lung cancer: The presence of p40-positive cells does not always indicate squamous differentiation.
    Nakajima N; Yoshizawa A; Moriyoshi K; Sonobe M; Menju T; Sumiyoshi S; Date H; Haga H
    Thorac Cancer; 2019 May; 10(5):1188-1192. PubMed ID: 30957413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic features and genetic profile of the redefined large cell lung carcinoma].
    Hou LK; Zhang LP; Zhang W; Huang Y; Wu W; Dong ZW; Wu CY
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):298-302. PubMed ID: 28468033
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
    Lyda MH; Weiss LM
    Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer.
    Koyi H; Brandén E; Kasim I; Wilander E
    Anticancer Res; 2018 Jun; 38(6):3341-3346. PubMed ID: 29848682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation.
    Righi L; Graziano P; Fornari A; Rossi G; Barbareschi M; Cavazza A; Pelosi G; Scagliotti GV; Papotti M
    Cancer; 2011 Aug; 117(15):3416-23. PubMed ID: 21246522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of protein markers in combination with ThinPrep bronchial brush cytology in classification of lung cancer subtypes].
    Yang Y; Pan QJ; Teng MF; Li ZL; Zhao LL; Han NJ; Gao YN; Cao J
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):616-9. PubMed ID: 19102942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
    Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
    Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-small cell lung cancer. New biomarkers for diagnostics and therapy].
    Kayser G
    Pathologe; 2015 Nov; 36 Suppl 2():189-93. PubMed ID: 26391246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.